Virax Biolabs Group Ltd. (VRAX)
1.99
-0.12
(-5.69%)
USD |
NASDAQ |
Oct 08, 12:30
Virax Biolabs Group Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Interpace Biosciences, Inc. | 31.53M |
| Akso Health Group | 1.042B |
| AstraZeneca PLC | 522.93B |
| GSK Plc | 114.57B |
| PD-Rx Pharmaceuticals, Inc. | -- |
Enterprise Value Related Metrics
| Earnings Yield | -849.8% |
| Normalized Earnings Yield | -849.81 |